Total Voting Rights
In brief · summary, not quotable
Oxford Biomedica’s issued share capital at close of business on 31 October 2026 consisted of 121,459,900 ordinary shares of 50 pence each, with no ordinary shares held in treasury, giving total voting rights of 121,459,900; shareholders should use 121,459,900 as the denominator for FCA notification thresholds.
Full announcement
The text of this announcement could not be extracted (it is probably a PDF or an image). Read it at the source ↗
View the original announcement ↗ · Company filings. Not investment advice.